Finrest
Finrest Price range: $ 38,00 through $ 109,00
Back to products
Flexeril
Flexeril Price range: $ 57,00 through $ 648,00

Flagyl ER

Price range: $ 44,00 through $ 139,00

Flagyl ER is an advanced extended-release antibiotic specifically formulated to treat certain bacterial infections. This medication is primarily indicated for the effective treatment of bacterial vaginosis in adult women. By utilizing metronidazole as its active ingredient, it targets and eliminates the overgrowth of harmful anaerobic bacteria. The extended-release delivery system ensures a consistent level of medication in the bloodstream with the convenience of once-daily dosing. Flagyl ER helps restore healthy internal balance by successfully clearing the underlying infection.

Active substance: Metronidazole
SKU: Flagyl ER Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Flagyl ER: Extended-Release Information for Patients

Flagyl ER belongs to a group of synthetic antibacterial and antiprotozoal agents known as nitroimidazoles. It is an extended-release formulation containing metronidazole, prescribed primarily for the treatment of bacterial vaginosis in adult non-pregnant women. As a prescription-only oral medication regulated by the US Food and Drug Administration (FDA), Flagyl ER must be dispensed and administered under the supervision of a licensed healthcare provider.

Extended-release metronidazole relies on a controlled-release matrix to deliver the active drug substance gradually over a 24-hour period. Understanding its pharmacokinetic profile, dosing requirements, drug interactions, and potential adverse effects ensures optimal clinical efficacy while minimizing risk.

Property Details
Active ingredient Metronidazole
Dosage form Extended-release oral tablet
Primary purpose Treatment of bacterial vaginosis
Prescription status Prescription (Rx) only
Route of administration Oral
Storage Store at 20°C to 25°C (68°F to 77°F)

Main uses

Flagyl ER is indicated exclusively for the treatment of bacterial vaginosis in adult women. Diagnosis of bacterial vaginosis must be confirmed using clinical criteria or laboratory testing, such as a Gram stain or wet mount demonstrating clue cells. Metronidazole exhibits targeted antimicrobial activity against anaerobic micro-organisms involved in bacterial vaginosis, including Gardnerella vaginalis, Bacteroides species, and Mobiluncus species. Prescribing Flagyl ER in the absence of a proven or strongly suspected bacterial infection is avoided to lower the risk of developing drug-resistant bacteria. Any application of extended-release metronidazole outside of FDA-approved microbial vaginosis indications is classified as off-label and requires direct medical oversight.

How the drug works

Metronidazole acts as a synthetic nitroimidazole antimicrobial agent. Once absorbed, the uncharged molecule diffuses across cell membranes into the cytoplasm of susceptible anaerobic organisms. Intracellular electron transport proteins reduce the nitro group of metronidazole to an unstable intermediate compound. This reduced metabolite binds directly to bacterial DNA, causing strand breakage, destabilization of the double helix structure, and inhibition of nucleic acid synthesis, ultimately resulting in cell death. Human host cells lack the necessary electron transport proteins to reduce metronidazole efficiently, conferring selective antimicrobial toxicity toward anaerobic pathogens.

What happens in the body

Following oral administration, Flagyl ER utilizes a polymer matrix system to release metronidazole steadily over a 24-hour interval. Peak plasma concentration (Cmax) is reached significantly later compared to immediate-release metronidazole formulations, providing sustained systemic exposure without sharp peak-to-trough plasma level fluctuations. Systemic bioavailability is influenced by food; taking Flagyl ER under fasting conditions maintains predictable therapeutic drug levels. Metronidazole is broadly distributed into body tissues and fluids, including secretions of the reproductive tract. Metabolism occurs in the liver primarily via side-chain oxidation and hydroxylation. The elimination half-life of metronidazole is approximately 8 hours, with 60% to 80% of the drug excreted through the renal system as unchanged active drug and urinary metabolites.

Dosing schedule

The standard clinical regimen of Flagyl ER for bacterial vaginosis is 750 mg taken orally once daily for 7 consecutive days. To maintain consistent systemic absorption, Flagyl ER must be taken on an empty stomach–at least 1 hour before or 2 hours after a meal. Extended-release tablets must be swallowed whole with water; patients must not crush, chew, split, or break the tablets, as damaging the matrix causes immediate drug release and disrupts the intended extended-release pharmacokinetics. Adherence to the complete 7-day therapeutic course is critical to eradicate the underlying infection and mitigate antimicrobial resistance.

Safety Profile and Important Considerations

Adverse Reactions and Neurological Warnings

Clinical trials and post-marketing surveillance indicate that common side effects of Flagyl ER include headache, nausea, metallic taste, abdominal distress, diarrhea, and genital pruritus or vulvovaginal candidiasis. Serious adverse events primarily involve the central and peripheral nervous systems. Metronidazole therapy has been associated with convulsive seizures, peripheral neuropathy characterized by numbness or paresthesia in extremities, and encephalopathy. The appearance of abnormal neurological signs warrants immediate cessation of Flagyl ER and clinical evaluation. Additionally, metronidazole has demonstrated carcinogenic activity in animal rodent models; unnecessary or prolonged exposure should be avoided.

Compatibility with Other Medicines

Metronidazole demonstrates significant pharmacological interactions with several drug classes:

  • Oral Anticoagulants (e.g., Warfarin): Metronidazole inhibits hepatic metabolism of warfarin, enhancing its anticoagulant effect and prolonging prothrombin time (INR). Frequent monitoring of prothrombin time is recommended during co-therapy.
  • Disulfiram: Combined administration can precipitate acute psychotic reactions and cognitive confusion. Metronidazole should not be prescribed to patients who have taken disulfiram within the preceding two weeks.
  • Lithium: Metronidazole may increase serum lithium concentrations, elevating the risk of lithium-induced renal toxicity. Serum lithium and creatinine levels should be monitored closely if concurrent use is necessary.
  • Busulfan: Metronidazole can increase plasma concentrations of busulfan, leading to severe busulfan toxicity.
  • CYP Enzyme Modulators: Inducers of hepatic microsomal enzymes, such as phenobarbital, accelerate metronidazole elimination, whereas inhibitors like cimetidine can prolong metronidazole clearance.

What to Avoid While Taking It

Alcoholic beverages and preparations containing ethanol or propylene glycol must be completely avoided during treatment with Flagyl ER and for at least 72 hours following the final dose. Consuming alcohol while metronidazole is present in systemic circulation disrupts alcohol metabolism, producing a disulfiram-like reaction characterized by severe abdominal cramping, nausea, vomiting, facial flushing, headache, and palpitations. Additionally, patients must avoid consuming food simultaneously with tablet intake, as food presence reduces the area under the concentration-time curve (AUC) of extended-release metronidazole.

Special populations

In pregnant patients, metronidazole crosses the placental barrier. While FDA product labeling advises caution, use during pregnancy is reserved for clinical situations where therapeutic benefit clearly outweighs potential fetal risks. Metronidazole is secreted into human milk in concentrations comparable to maternal plasma levels; a decision should be made whether to discontinue nursing or discontinue Flagyl ER, taking into account the mother’s clinical need for the drug. In patients with severe hepatic impairment, metronidazole metabolism is delayed, leading to potential drug accumulation; lower total daily doses or altered dosing schedules may be required. Safety and effectiveness in pediatric populations have not been evaluated.

If you skip a dose

If a dose of Flagyl ER is missed, it should be taken on an empty stomach as soon as remembered. However, if the time is close to the next scheduled administration, the missed dose should be omitted and the regular schedule resumed. Patients must not double the dose to compensate for a missed tablet. Maintaining regular dosing intervals is essential to preserve therapeutic blood levels throughout the treatment period.

Storage and expiration

Flagyl ER tablets should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). Tablets must be protected from light and excessive moisture by keeping them in a tightly closed container. Do not use the medication past the expiration date stated on the package label. All prescription medicines should be stored out of reach of children and domestic animals.

Common Questions

Why must Flagyl ER be taken on an empty stomach?

Ingestion of food alongside extended-release metronidazole significantly decreases overall drug absorption (AUC). Administering the tablet at least 1 hour before or 2 hours after food ensures optimal bioavailability and consistent plasma levels required to eradicate target bacteria.

How long after completing Flagyl ER must alcohol be avoided?

Ethanol must be avoided during the full 7 days of treatment and for a minimum of 72 hours (3 days) after taking the last dose. This window ensures metronidazole and its active metabolites are cleared from the systemic circulation, preventing disulfiram-like reactions.

Can Flagyl ER tablets be split or crushed for easier swallowing?

No. Flagyl ER tablets contain a specialized extended-release matrix designed to release metronidazole slowly over 24 hours. Breaking, crushing, or chewing the tablet destroys this controlled-release delivery system, leading to rapid drug absorption and potential adverse reactions.

What should be done if a dose of Flagyl ER is missed?

Take the missed tablet on an empty stomach as soon as remembered. If it is almost time for the next scheduled dose, skip the missed dose completely and continue with the standard schedule. Doubling up on doses is unsafe and medically improper.

Are neurological symptoms like tingling in hands or feet expected during treatment?

No. Numbness, tingling, or weakness in the hands or feet are symptoms of peripheral neuropathy, a documented central/peripheral nervous system warning associated with metronidazole. If these symptoms occur, medication should be stopped and evaluated by a medical professional immediately.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

200mg

,

400mg

Package

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία